Intravenous administration of expanded allogeneic adipose-derived mesenchymal stem cells in refractory rheumatoid arthritis (Cx611): results of a multicentre, dose …
JM Álvaro-Gracia, JA Jover, R García-Vicuña… - Annals of the …, 2017 - ard.bmj.com
Objectives To evaluate the safety and tolerability of the intravenous administration of Cx611,
a preparation of allogeneic expanded adipose-derived stem cells (eASCs), in patients with …
a preparation of allogeneic expanded adipose-derived stem cells (eASCs), in patients with …
Intravenous administration of expanded allogeneic adipose-derived mesenchymal stem cells in refractory rheumatoid arthritis (Cx611): results of a multicentre, dose …
J Álvaro-Gracia, J Jover, R García-Vicuña… - Annals of Rheumatic …, 2016 - ora.ox.ac.uk
Objectives To evaluate the safety and tolerability of the intravenous administration of Cx611,
a preparation of allogeneic expanded adipose-derived stem cells (eASCs), in refractory …
a preparation of allogeneic expanded adipose-derived stem cells (eASCs), in refractory …
[引用][C] Intravenous administration of expanded allogeneic adipose-derived mesenchymal stem cells in refractory rheumatoid arthritis (Cx611): Results of a multicentre …
JM Álvaro-Gracia, JA Jover… - Annals of the …, 2017 - produccioncientifica.ucm.es
Objectives To evaluate the safety and tolerability of the intravenous administration of Cx611,
a preparation of allogeneic expanded adipose-derived stem cells (eASCs), in patients with …
a preparation of allogeneic expanded adipose-derived stem cells (eASCs), in patients with …
Intravenous administration of expanded allogeneic adipose-derived mesenchymal stem cells in refractory rheumatoid arthritis (Cx611): results of a multicentre, dose …
JA Jover, R Garcia-Vicuna, L Carreno… - Annals of the …, 2017 - search.proquest.com
Objectives To evaluate the safety and tolerability of the intravenous administration of Cx611,
a preparation of allogeneic expanded adipose-derived stem cells (eASCs), in patients with …
a preparation of allogeneic expanded adipose-derived stem cells (eASCs), in patients with …
[引用][C] Intravenous administration of expanded allogeneic adipose-derived mesenchymal stem cells in refractory rheumatoid arthritis (Cx611): Results of a multicentre …
JM Álvaro-Gracia, JA Jover… - Annals of the …, 2017 - portalciencia.ull.es
Intravenous administration of expanded allogeneic adipose-derived mesenchymal stem cells
in refractory rheumatoid arthritis (Cx611): Results of a multicentre, dose escalation …
in refractory rheumatoid arthritis (Cx611): Results of a multicentre, dose escalation …
Intravenous administration of expanded allogeneic adipose-derived mesenchymal stem cells in refractory rheumatoid arthritis (Cx611): results of a multicentre, dose …
JM Álvaro-Gracia, JA Jover… - Annals of the …, 2017 - pubmed.ncbi.nlm.nih.gov
Objectives To evaluate the safety and tolerability of the intravenous administration of Cx611,
a preparation of allogeneic expanded adipose-derived stem cells (eASCs), in patients with …
a preparation of allogeneic expanded adipose-derived stem cells (eASCs), in patients with …
Intravenous administration of expanded allogeneic adipose-derived mesenchymal stem cells in refractory rheumatoid arthritis (Cx611): results of a multicentre, dose …
JM Álvaro-Gracia, JA Jover, R García-Vicuña… - Annals of the …, 2016 - cir.nii.ac.jp
抄録< jats: sec>< jats: title> Objectives</jats: title>< jats: p> To evaluate the safety and
tolerability of the intravenous administration of Cx611, a preparation of allogeneic expanded …
tolerability of the intravenous administration of Cx611, a preparation of allogeneic expanded …
Intravenous administration of expanded allogeneic adipose-derived mesenchymal stem cells in refractory rheumatoid arthritis (Cx611): results of a multicentre, dose …
JM Álvaro-Gracia, JA Jover, R García-Vicuña… - Annals of the …, 2017 - ard.bmj.com
Objectives To evaluate the safety and tolerability of the intravenous administration of Cx611,
a preparation of allogeneic expanded adipose-derived stem cells (eASCs), in patients with …
a preparation of allogeneic expanded adipose-derived stem cells (eASCs), in patients with …
Intravenous administration of expanded allogeneic adipose-derived mesenchymal stem cells in refractory rheumatoid arthritis (Cx611): results of a multicentre, dose …
JM Álvaro-Gracia, JA Jover… - Annals of the …, 2016 - europepmc.org
Objectives To evaluate the safety and tolerability of the intravenous administration of Cx611,
a preparation of allogeneic expanded adipose-derived stem cells (eASCs), in patients with …
a preparation of allogeneic expanded adipose-derived stem cells (eASCs), in patients with …
[引用][C] Intravenous administration of expanded allogeneic adipose-derived mesenchymal stem cells in refractory rheumatoid arthritis (Cx611): Results of a multicentre …
JM Álvaro-Gracia, JA Jover… - Annals of the …, 2017 - portalciencia.ull.es
Intravenous administration of expanded allogeneic adipose-derived mesenchymal stem cells
in refractory rheumatoid arthritis (Cx611): Results of a multicentre, dose escalation …
in refractory rheumatoid arthritis (Cx611): Results of a multicentre, dose escalation …